Visto, Ricardo M.
HRN: 22-75-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2023
CEFTRIAXONE 1G (VIAL)
04/13/2023
04/20/2023
IV
2g
Q24
Cholangitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes